基础医学与临床 ›› 2025, Vol. 45 ›› Issue (11): 1420-1428.doi: 10.16352/j.issn.1001-6325.2025.11.1420

• 研究论文 • 上一篇    下一篇

3-甲基腺嘌呤改善糖尿病模型小鼠肾小球系膜扩张及细胞外基质沉积

任海文1, 胡杰1, 谭海波1, 龚权2, 刘本菊2, 陈继德1*   

  1. 1.重庆医科大学附属璧山医院 医学检验科,重庆 402760;
    2.长江大学 医学部 基础医学院,湖北 荆州 434020
  • 收稿日期:2024-12-02 修回日期:2025-02-24 出版日期:2025-11-05 发布日期:2025-10-24
  • 通讯作者: *Kevin202071853@163.com
  • 基金资助:
    国家自然科学基金(82270893);重庆市璧山区社会民生领域科技计划(BSKJ2024073);湖北省卫生健康委员会医学科研联合发展基金(WJ2019-16)

3-Methyladenine improves mesangial dilation and extracellular matrix deposition in mouse models with diabetes

REN Haiwen1, HU Jie1, TAN Haibo1, GONG Quan2, LIU Benju2, CHEN Jide1*   

  1. 1. Department of Clinical Laboratory, Bishan Hospital Affiliated to Chongqing Medical University, Chongqing 402760;
    2. School of Basic Medicine, Yangtze University Health Science Center, Jingzhou 434020, China
  • Received:2024-12-02 Revised:2025-02-24 Online:2025-11-05 Published:2025-10-24
  • Contact: *Kevin202071853@163.com

摘要: 目的 探讨3-甲基腺嘌呤(3-MA)对高糖培养的小鼠肾小球系膜细胞系MES-13的影响,以及对链脲佐菌素(STZ)诱导的糖尿病小鼠肾脏的影响及机制。方法 体外实验:将MES-13细胞分为低糖对照组(LG)、甘露醇高渗透压对照组(HOP)、高糖组(HG)、3-甲基腺嘌呤+高糖组(HG+3-MA)、氯喹+高糖组(HG+CQ),分别给予低糖DMEM、30 mmol/L甘露醇高渗对照培养基、30 mmol/L高糖培养基、5 mmol/L 3-MA+30 mmol/L高糖培养基、10 mmol/L CQ+30 mmol/L高糖培养基处理24 h后进行CCK-8法测定和蛋白质印迹分析。体内实验:雄性C57BL/6J小鼠通过连续5 d注射STZ 60 mg/kg诱导糖尿病小鼠模型,于注射STZ溶液2周随机血糖高于16.7 mmol/L(250 mg/dL)的小鼠随机分为糖尿病对照组(DM)、3-MA干预组(DM+3-MA)和CQ干预组(DM+CQ),并与正常对照组(NC)小鼠在相同条件下饲养。DM+3-MA组每天灌胃3-MA水溶液10 mg/kg,DM+CQ组每隔3 d腹腔注射CQ 50 mg/kg,NC组和DM组给予等量0.9%氯化钠溶液,持续6周后麻醉处死,剥离肾脏测定肾/体质量比、糖原染色(PAS)、MASSON染色和蛋白质印迹分析。结果 体外实验:与LG组相比, HG组细胞活力、PCNA表达、磷酸化Akt与总Akt的比值(p-Akt/Akt)以及磷酸化rpS6与总rpS6的比值(p-rpS6/rpS6)显著增加(P<0.05)。与HG组相比,HG+3-MA组和HG+CQ组细胞活力、PCNA以及p-Akt/Akt比值均显著下调,HG+3-MA组细胞p-rpS6/rpS6比值显著下调(P<0.01);体内实验:与NC组相比,DM组小鼠肾/体质量比、肾小球体积、肾小管损伤指数、PCNA、fibronectin、COL1A1、p-Akt/Akt、p-rpS6/rpS6显著上调(P<0.05)。与DM组相比,DM+3-MA组小鼠肾/体质量比、肾小球体积、肾小管损伤指数、PCNA、fibronectin、COL1A1、p-Akt/Akt、p-rpS6/rpS6显著下调(P<0.05)。结论 3-MA可改善早期糖尿病肾病(DN)肾小球系膜细胞增殖扩张和肾ECM沉积,3-MA改善早期DN可能与其抑制Akt/rpS6信号通路有关。

关键词: 3-甲基腺嘌呤, 糖尿病肾病, 系膜细胞, 细胞外基质

Abstract: Objective To investigate the effects of 3-methyladenine (3-MA) on mouse mesangial cell line MES-13 cultured in high glucose, and on the kidney of streptozotocin (STZ) - induced mouse model of diabetes and the potential mechanism. Methods MES-13 cells were divided into low glucose control group (LG), hyper osmotic pressure control group (HOP), high glucose group (HG), 3-methyladenine+high glucose group (HG+3-MA)and chloroquine+high glucose group (HG+CQ).The groups were respectively incubated with low glucose DMEM, 30 mmol/L mannitol hypertonic control medium, 30 mmol/L high glucose medium, 5 mmol/L 3-MA+30 mmol/L high glucose medium and 10 mmol/L CQ+30 mmol/L high glucose medium for 24 hours. CCK-8 assay and Western blot were performed. In vivo experiment: Male C57BL/6J mice were induced diabetes for model development by intra-peritoneal injection of STZ 60 mg/kg for five consecutive days. After two weeks of injection, the blood glucose was measured. Animals with blood glucose level higher than 16.7 mmol/L (250 mg/dL) were randomly divided into diabetes control group (DM), 3-MA intervention group (DM+3-MA) and CQ intervention group (DM+CQ), then were fed under the same conditions as normal control group (NC) mice. The DM+3-MA group was given 10 mg/kg of 3-MA aqueous solution by gavage every day, the DM+CQ group was given 50 mg/kg of CQ by intraperitoneal injection every three days, the NC group and DM group were given the same amount of normal saline and killed after 6 weeks. The kidneys were stripped for kidney/body weight ratio determination, periodic acid-schiff staining (PAS), MASSON staining microscopy and Western blot. Results In vitro experiment: Compared to the LG group, the cell viability, PCNA expression, ratio of phosphorylated Akt to total Akt (p-Akt/Akt) and ratio of phosphorylated rpS6 to total rpS6 (p-rpS6/rpS6) were significantly increased in the HG group (P<0.05). Compared with HG group, the cell viability, PCNA and p-Akt/Akt ratio of HG+3-MA group and HG+CQ group were significantly decreased and p-rpS6/rpS6 ratio of HG+3-MA group was significantly decreased(P<0.01). In vivo experiment: Compared to NC group, the kidney/body weight ratio, glomerular volume, renal tubular injury index, PCNA, fibronectin, COL1A1, p-Akt/Akt, p-rpS6/rpS6 in DM group were all significantly up-regulated(P<0.05). Compared with DM group, the kidney/body weight ratio, glomerular volume, renal tubular injury index, PCNA, fibronectin, COL1A1, p-Akt/Akt, p-rpS6/rpS6 of DM+3-MA group mice were all significantly decreased(P<0.05). Conclusions 3-MA can improve glomerular mesangial cell proliferation and renal ECM deposition in early diabetes nephropathy (DN). The improvement of 3-MA in early DN may be related to the inhibition of Akt/rpS6 signaling pathway.

Key words: 3-methyladenine, diabetes nephropathy, mesangial cell, extra cellular matrix

中图分类号: